EGFR and cancer: This is a broad family that includes four components, EGFR (HER1), HER2, HER3 and HER4, and is assigned to receptor tyrosine kinase (RTK) type I. It has an important role in the control of key signaling pathways that are related to cancer-cell growth, proliferation, migration and survival.